InMed Pharmaceuticals Inc. — Company profile
Healthcare · Drug Manufacturers - Specialty & Generic · Canada
Last price 1.6 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 10.63M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Company profile
InMed Pharmaceuticals Inc. operates as a pharmaceutical drug development company in the United States. The company researches and develops cannabinoid-based pharmaceuticals products. Its product candidates include INM-901 for Alzheimer’s disease, INM-089 for dry age-related macular degeneration, and INM-755, a cannabinol cream. The company was formerly known as Cannabis Technologies Inc. and changed its name to InMed Pharmaceuticals Inc. in October 2014. InMed Pharmaceuticals Inc. was incorporated in 1981 and is based in Vancouver, Canada.
Details
| Name | InMed Pharmaceuticals Inc. |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Employees | 6 |
| Founded | 1981 |
| Ceo | Eric Adams |
| Country | Canada |
| Exchange | NASDAQ |
| Fiscal Year | July - June |
| Reporting Currency | USD |
| Isin | CA4576377002 |
| Cusip | 457637700 |
| Cik | 1728328 |
| Sic | 2834 |
Key executives
| Name | Title |
|---|---|
| Eric A. Adams B.S. Chem., M.I.B. | President, Chief Executive Officer and Director |
| N. Netta Jagpal | Chief Financial Officer and Corporate Secretary |
| Michael Woudenberg P.Eng. | Chief Operating Officer |
| Dr. Eric Chih-Hsien Hsu Ph.D. | Senior Vice President of Preclinical Research and Development |
| Dr. Sazzad Hossain M.Sc., Ph.D. | Co-Founder |
| Colin Clancy | Vice President of Investor Relations and Corporate Communications |
| Jerry P. Griffin | Vice President of Sales and Marketing |
Contact
| Address | 500 West Georgia Street, Suite 1800, Vancouver, BC V6B 0M3, Canada |
| Phone | 604 669 7207 |
| Website | https://www.inmedpharma.com |